Treatment of Exudative Age-related Macular Degeneration: Focus on Aflibercept

A formulation of aflibercept for intravitreal injection (Eylea) is approved for the treatment of patients with exudative age-related macular degeneration (AMD). Aflibercept has a significantly higher affinity for Vascular endothelial growth factor (VEGF)-A compared with other monoclonal anti-VEGF an...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Drugs Aging
Hoofdauteurs: García-Layana, Alfredo, Figueroa, Marta S., Araiz, Javier, Ruiz-Moreno, José M., Gómez-Ulla, Francisco, Arias-Barquet, Luis, Reiter, Nicholas
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Springer International Publishing 2015
Onderwerpen:
Review Article
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4607716/
https://ncbi.nlm.nih.gov/pubmed/26442858
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40266-015-0300-y
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items